APA (7th ed.) Citation

Mayer, E. L., DeMichele, A., Rugo, H. S., Miller, K., Waks, A. G., Come, S. E., . . . Burstein, H. J. (2019). A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma. Annals of Oncology, 30(9), 1514. https://doi.org/10.1093/annonc/mdz198

Chicago Style (17th ed.) Citation

Mayer, E L., et al. "A Phase II Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor-positive Invasive Breast Carcinoma." Annals of Oncology 30, no. 9 (2019): 1514. https://doi.org/10.1093/annonc/mdz198.

MLA (9th ed.) Citation

Mayer, E L., et al. "A Phase II Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor-positive Invasive Breast Carcinoma." Annals of Oncology, vol. 30, no. 9, 2019, p. 1514, https://doi.org/10.1093/annonc/mdz198.